Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 38 881,33 ₴, with a 24-hour trading volume of 151,15B ₴. The asset's market cap is 34,73T ₴, after moving -3.67% in the last day.
Tokenized Eli Lilly And Co is trading at 38 878,51 ₴, with a tokenized market cap of 211,34M ₴ and a 24-hour trading volume of 71,29M ₴. The tokenized asset has moved -1.13% in the past 24 hours.